Literature DB >> 15383018

The independent association of massive blood loss with mortality in cardiac surgery.

Keyvan Karkouti1, Duminda N Wijeysundera, Terrence M Yau, W Scott Beattie, Esamelden Abdelnaem, Stuart A McCluskey, Mohammed Ghannam, Eric Yeo, George Djaiani, Jacek Karski.   

Abstract

BACKGROUND: Although the association between massive perioperative blood loss (MBL) and adverse outcomes is well recognized, it is unclear whether MBL is an independent risk factor or, instead, simply a marker for other adverse events or severity of illness. The objective of this cohort study was to quantify the independent association of MBL in cardiac surgery with all-cause in-hospital mortality. STUDY DESIGN AND METHODS: Data were prospectively collected on consecutive patients who underwent cardiac surgery with cardiopulmonary bypass at a quaternary-care academic center from 1999 to 2003. The number of red blood cell (RBC) units transfused within 1 day of surgery was used as a surrogate measure of perioperative blood loss. Receiver-operating characteristic curve analyses were employed to identify the most appropriate cutoff for defining MBL. The independent association of MBL with mortality was determined with multivariable logistic regression analyses. Bootstrapping and sensitivity analyses were used to confirm the validity of the results.
RESULTS: MBL was defined as receiving at least 5 units of RBCs within 1 day of surgery. Of 9215 patients analyzed, 1.8 percent (n = 169) died and 9.7 percent (n = 890) had MBL. After adjusting for multiple potential confounders (including perioperative adverse events), MBL was associated with an 8.1-fold (95% confidence interval, 3.9-17.0) increase in the odds of death. This risk estimate was stable across different modeling conditions as well as in bootstrap sampling.
CONCLUSION: MBL after cardiac surgery has a strong, independent association with in-hospital mortality.

Entities:  

Mesh:

Year:  2004        PMID: 15383018     DOI: 10.1111/j.1537-2995.2004.04144.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  64 in total

1.  Seizure treatment in transplant patients.

Authors:  Paul W Shepard; Erik K St Louis
Journal:  Curr Treat Options Neurol       Date:  2012-08       Impact factor: 3.598

2.  In Reply.

Authors:  Miklos D Kertai; Shan Zhou; Jörn A Karhausen; Mary Cooter; Edmund Jooste; Yi-Ju Li; William D White; Solomon Aronson; Mihai V Podgoreanu; Jeffrey Gaca; Ian J Welsby; Jerrold H Levy; Mark Stafford-Smith; Joseph P Mathew; Manuel L Fontes
Journal:  Anesthesiology       Date:  2016-08       Impact factor: 7.892

3.  Patterns of use of hemostatic agents in patients undergoing major surgery.

Authors:  Jason D Wright; Cande V Ananth; Sharyn N Lewin; William M Burke; Zainab Siddiq; Alfred I Neugut; Thomas J Herzog; Dawn L Hershman
Journal:  J Surg Res       Date:  2013-08-13       Impact factor: 2.192

Review 4.  Is there still a role for aprotinin in cardiac surgery?

Authors:  Neel R Sodha; Munir Boodhwani; Frank W Sellke
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

5.  Changes in activated partial thromboplastin time and international normalised ratio after on-pump and off-pump surgical revascularization of the heart.

Authors:  Lejla Selimović Čeke; Semir Imamović; Farid Ljuca; Zoran Jerkić; Goran Imamović; Munevera Hadžimešić; Aida Pojskić; Jasmina Kovčić
Journal:  Bosn J Basic Med Sci       Date:  2014-05       Impact factor: 3.363

Review 6.  Thrombin generation and bleeding in cardiac surgery: a clinical narrative review.

Authors:  John Fitzgerald; Robert McMonnies; Aidan Sharkey; Peter L Gross; Keyvan Karkouti
Journal:  Can J Anaesth       Date:  2020-03-04       Impact factor: 5.063

Review 7.  [Cardiopulmonary bypass in cardiac surgery].

Authors:  T Baehner; O Boehm; C Probst; B Poetzsch; A Hoeft; G Baumgarten; P Knuefermann
Journal:  Anaesthesist       Date:  2012-10       Impact factor: 1.041

8.  Cytocompatibility and mechanical properties of surgical sealants for cardiovascular applications.

Authors:  Mark H Murdock; Jordan T Chang; Samuel K Luketich; Drake Pedersen; George S Hussey; Antonio D'Amore; Stephen F Badylak
Journal:  J Thorac Cardiovasc Surg       Date:  2018-09-01       Impact factor: 5.209

9.  Association of the 98T ELAM-1 polymorphism with increased bleeding after cardiac surgery.

Authors:  Ian J Welsby; Mihai V Podgoreanu; Barbara Phillips-Bute; Richard Morris; Joseph P Mathew; Peter K Smith; Mark F Newman; Debra A Schwinn; Mark Stafford-Smith
Journal:  J Cardiothorac Vasc Anesth       Date:  2010-01-06       Impact factor: 2.628

10.  Recombinant factor VII is associated with worse survival in complex cardiac surgical patients.

Authors:  Andrej Alfirevic; Andra Duncan; Jing You; Cheryl Lober; Edward Soltesz
Journal:  Ann Thorac Surg       Date:  2014-06-24       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.